Iodine-131 (I-131)
Smarter therapy
&
Precise performance
&
Precise performance
Features
- Dual-Mode Utility: Enables both imaging and therapeutic applications.
- Reliable Quality: Manufactured by Ganti Radioisotopes under strict cGMP standards.
- Flexible Formulations: Available as Sodium Iodide (NaI-131) in capsule or liquid form.
- Proven Clinical Efficacy: Extensively validated in global nuclear medicine practice.
Iodine-131 (I-131) is one of the most established and effective radioisotopes in nuclear medicine. With its dual beta and gamma emissions, it plays a crucial role in both diagnostic imaging and targeted radiotherapy, particularly for thyroid disorders and cancer treatment.
Applications
- Thyroid cancer ablation and metastases treatment
- Hyperthyroidism (Graves’ disease, toxic nodules) therapy
- Diagnostic imaging of thyroid uptake and function
- Research and development in nuclear medicine
Technical Specifications
| Property | Details |
|---|---|
| Isotope | Iodine-131 (I-131) |
| Half-life | ~8.02 days |
| Decay Type | Beta (β⁻) and Gamma (γ) |
| Gamma Energy | 364 keV |
| Chemical Form | Sodium Iodide (NaI) in NaOH/Na₂S₂O₃ solution |
| Radiochemical Purity | ≥99% |
| Packaging Options | Sealed vial, capsule, or liquid form |
| Compliance | WHO GMP / ISO / IAEA standards |